Stephen D. Simpson, CFA

  1. Stryker Moves On From A Long Mistake
    Stock Analysis

    Stryker Moves On From A Long Mistake

    Stryker finally rids itself of a long-failed product. Find out if this othopedic devices manufacturer is poised for growth.
  2. FDA's Bizarro World - Orexigen Gets Panel Approval!
    Stock Analysis

    FDA's Bizarro World - Orexigen Gets Panel Approval!

    In a surprise decision, an FDA panel votes to approve Contrave, Orexigen's new obesity drug.
  3. More M&A In Met Mining?
    Stock Analysis

    More M&A In Met Mining?

    Met coal is a hot area now; maybe too hot for most investors to start new positions.
  4. Should Investors Pay Any Price For VeriFone?
    Stock Analysis

    Should Investors Pay Any Price For VeriFone?

    VeriFone has solid growth prospects but an incredibly demanding valuation.
  5. Avago Looks Like A Relative Bargain
    Stock Analysis

    Avago Looks Like A Relative Bargain

    Avago should stand out a bit from the analog chip crowd.
  6. A Melancholy
    Stock Analysis

    A Melancholy "Do Svidaniya" To Wimm-Bill-Dann

    Pepsico takes out one of the best Russian stocks available to American investors.
  7. Merck Makes A Smart Buy
    Stock Analysis

    Merck Makes A Smart Buy

    Merck is making an exciting bet on a possible diabetes breakthrough.
  8. The Story Behind The Irish Meltdown
    Personal Finance

    The Story Behind The Irish Meltdown

    Once a lesson in national renewal, Ireland is learning that success can be fleeting. Learn the story behind Ireland's crumbling economy.
  9. Mellanox - To InfiniBand And Beyond?
    Stock Analysis

    Mellanox - To InfiniBand And Beyond?

    Mellanox makes a logical play to expand its InfiniBand product line.
  10. A Long-Awaited Move From ABB
    Stock Analysis

    A Long-Awaited Move From ABB

    ABB pays up for a quality asset that patches a hole in its product line.
  11. Santa's Financial Naughty List For 2010
    Personal Finance

    Santa's Financial Naughty List For 2010

    Santa is going to be shoveling a lot of coal for the financial world this year.
  12. Holiday Spending: 2010 Vs. 2009
    Personal Finance

    Holiday Spending: 2010 Vs. 2009

    A variety of data suggests there is a real, but slow, recovery.
  13. Should Investors Put Hormel On The Plate?
    Stock Analysis

    Should Investors Put Hormel On The Plate?

    Hormel is doing well, but the stock leaves little room for dessert.
  14. Cheap Stocks Can Be Deceiving
    Investing Basics

    Cheap Stocks Can Be Deceiving

    Find out how to tell a truly undervalued stock from one that has been legitimately beaten down.
  15. HP Is Cheap - But Does Anybody Care?
    Stock Analysis

    HP Is Cheap - But Does Anybody Care?

    HP seems far too cheap relative to even conservative expectations.
  16. A User's Guide To Warrants
    Options & Futures

    A User's Guide To Warrants

    These investment vehicles are relatively uncommon in the United States, but they do still appear in U.S. markets.
  17. Everything Has Caught Up To Analog Devices
    Stock Analysis

    Everything Has Caught Up To Analog Devices

    Analog is executing well, but investors already expected that.
  18. The Nuance Story Is Not All That Subtle
    Stock Analysis

    The Nuance Story Is Not All That Subtle

    Nuance Communications is growing well enough, but red flags may deem it off-limits to some investors.
  19. Who Stands To Benefit From QE2?
    Economics

    Who Stands To Benefit From QE2?

    With the Fed opening the tap again, some specific industries could see easy money come their way.
  20. Novell's Weird Public Journey Ends
    Stock Analysis

    Novell's Weird Public Journey Ends

    Novell's run as a public company comes to an inglorious end.
  21. Apply Patience To Applied Materials
    Stock Analysis

    Apply Patience To Applied Materials

    Applied Materials is a value stock in a sector that seldom appreciates value.
  22. Salesforce.com And A Valuation In The Clouds
    Stock Analysis

    Salesforce.com And A Valuation In The Clouds

    Salesforce is growing well, but is it enough to fend off its formidable competition?
  23. Allegheny Becomes Broader Still
    Stock Analysis

    Allegheny Becomes Broader Still

    Allegheny takes another step beyond its history as an alloy specialist.
  24. MELA Sciences' New Device: Will It Be Approved?
    Stock Analysis

    MELA Sciences' New Device: Will It Be Approved?

    A surprising panel decision raises hopes, but offers no guarantees.
  25. Abercrombie & Fitch Back On Track
    Stock Analysis

    Abercrombie & Fitch Back On Track

    ANF seems to be back on its normal growth path.
  26. Limited Love For Life Sciences
    Stock Analysis

    Limited Love For Life Sciences

    Recent life sciences IPOs have landed with thud, which is a drastic contrast to the trends that were occuring just 10 years ago.
  27. Jacobs Still Looking To Build That Ladder
    Stock Analysis

    Jacobs Still Looking To Build That Ladder

    Jacobs closed out a tough year, but a quick rebound in large-scale construction seems improbable.
  28. Human Genome Takes A Big Step Forward
    Stock Analysis

    Human Genome Takes A Big Step Forward

    HGSI's prospects get a big boost from a panel approval.
  29. Caterpillar Now A Miner Major
    Stock Analysis

    Caterpillar Now A Miner Major

    Caterpillar makes a multi-billion dollar bet on the growth of mining.
  30. EMC Buys More Storage Space
    Stock Analysis

    EMC Buys More Storage Space

    EMC makes yet another move to maintain its dominance in enterprise storage.
  31. FDA Locked And Loaded For MELA Sciences
    Stock Analysis

    FDA Locked And Loaded For MELA Sciences

    A harsh FDA review sends MELA down sharply before a pivotal panel meeting.
  32. Kohl's Keeps It Simple
    Stock Analysis

    Kohl's Keeps It Simple

    Kohl's isn't bursting with growth, but it seems to be building a moat around its business. Is it enough to protect their market share?
  33. IGT Needs A Visit From Lady Luck
    Stock Analysis

    IGT Needs A Visit From Lady Luck

    Find out IGT's status in the gaming industry and if this gaming company can reclaim past glories.
  34. Archipelago Learning - Not All 'For Profit' Education Is ...
    Stock Analysis

    Archipelago Learning - Not All 'For Profit' Education Is ...

    Archipelago may be involved in education and profits, but it is a totally different type of company.
  35. Is Rockwell's Growth Automatic?
    Stock Analysis

    Is Rockwell's Growth Automatic?

    Rockwell has benefited from the industrial recovery, but investors have to wonder how much gain is left in the stock.
  36. Qiagen Hopes To Ride MDx
    Stock Analysis

    Qiagen Hopes To Ride MDx

    Qiagen doesn't seem to be earning the healthy esteem Wall Street has for the stock.
  37. With Minimal Expectations, Hologic Could Still Surprise
    Stock Analysis

    With Minimal Expectations, Hologic Could Still Surprise

    Hologic is suffering from low expectations, but value investors may have a bargain here.
  38. McDermott's New Life
    Stock Analysis

    McDermott's New Life

    McDermott should reap the ongoing expansion of offshore energy projects.
  39. Dark Days In Diabetes
    Stock Analysis

    Dark Days In Diabetes

    2010 has been a rough year in the diabetes space.
  40. 5 Long-Term Consequences Of The Recession
    Home & Auto

    5 Long-Term Consequences Of The Recession

    Apart from the headlines about jobs, this recession is doing damage in other areas that goes unnoticed.
  41. Sysco Still On Simmer
    Stock Analysis

    Sysco Still On Simmer

    Sysco is growing a bit, but not enough to be interesting.
  42. OM Group: Under The Radar, But Worth A Look
    Stock Analysis

    OM Group: Under The Radar, But Worth A Look

    OM Group is not widely known, but could be a relative value pick compared to other companies dealing in commodities.
  43. Two Green Energy Companies Moving In Different Directions
    Stock Analysis

    Two Green Energy Companies Moving In Different Directions

    Comparing these two companies now to five years ago shows how quickly fortunes change in emerging technologies.
  44. CAM-Do
    Stock Analysis

    CAM-Do

    Rising orders in the energy space point towards more activity, and increased profit potential.
  45. 5 Trendy Investment Ideas
    Markets

    5 Trendy Investment Ideas

    Here are some hot investing ideas a bit off the beaten paths.
  46. 7 Reasons To Pick ETFs Over Stocks
    Mutual Funds & ETFs

    7 Reasons To Pick ETFs Over Stocks

    ETFs have some significant advantages that investors should not ignore.
  47. Want A Strong Bank? Think ICICI
    Stock Analysis

    Want A Strong Bank? Think ICICI

    While domestic banking is still struggling, ICICI is benefiting from strong growth in India. Learn how this bank is profiting from India's emerging economy.
  48. M&T Bank Buys Scratch-And-Dent Wilmington Trust
    Stock Analysis

    M&T Bank Buys Scratch-And-Dent Wilmington Trust

    M&T buys the struggling Wilmington Trust and its lucrative fee-based businesses. Can MTB bring a shine back to this fixer-upper?
  49. Allergan Winning Wall Street's Beauty Pageant
    Stock Analysis

    Allergan Winning Wall Street's Beauty Pageant

    Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick on a pig, or does AGN have real beauty?
  50. Will Gorilla Make Corning King Of The Jungle?
    Stock Analysis

    Will Gorilla Make Corning King Of The Jungle?

    Corning has a promising new product, but its valuation seems difficult to justify.